The bioanalytical recession continues

“Many of us feel a heavy weight from a lack of funds, burdensome regulations and even anxiety over whether our positions will continue. All three discourage long-term thinking.” Four years ago Richard Abbott opined on these pages about the impact of the recession on bioanalysis in a wide ranging report, drilling down from the various pressures on Pharma at that time [1]. At least in the USA, the recession officially, but imperceptibly, ended in June of 2009 and thus 4 years later we would expect to be back to a more positive frame of mind. However, we are not! Several...